The 340B program was supposed to help hospitals care for low-income and uninsured patients. But over time, it’s turned into something very different. Instead of putting patients first, many hospitals now treat 340B as a major revenue generator – often with little benefit to the communities it was meant to support. An analysis conducted by Magnolia Market Access  reveals that the number of disproportionate share hospitals (DSHs) participating in 340B program has jumped 565% fr

By: Lisa M. Grabert, MPH, Visiting Professor of Research, Marquette University Hospitals across Michigan are exploiting a little-known federal program to squeeze millions of dollars from the state's poorest patients. Congress created the 340B Drug Pricing Program in 1992. It allows certain hospitals to purchase medicines from drug companies at substantial, mandatory discounts. Congress aimed for hospitals to reinvest these savings in patient care.

MILWAUKEE, WIS. (Nov. 18, 2025)  -- New research reveals that Michigan hospitals are making significant profits off a program designed to help low-income patients access affordable medicine without delivering community benefits.   That's among the key findings of an analysis conducted by Dr. Lisa Grabert , visiting research professor of health policy at Marquette University and former senior aide to the House Ways and Means Committee.   “Our analysis exposes a system that is

October 22, 2025 The Honorable Bill Cassidy, Chair The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor, and Pensions 428 Senate Dirksen Office Building Washington, DC 20510 Dear Chair Cassidy, Ranking Member Sanders, and Members of the Committee: On behalf of Community Action for Responsible Hospitals (CARH), representing the interests of workers, faith leaders, healthcare providers, and patient advocates, we appreciate the Committee’s a

A CARH study was featured in a Wall Street Journal editorial, citing analysis conducted by Magnolia Access Research of disproportionate...

WASHINGTON, D.C.  – Following the release of today’s Congressional Budget Office (CBO)  report  on the 340B Drug Pricing Program,...

Investments in Uncompensated Care and Vulnerable Populations Have Decreased on Average  While Hospital Investments in Financial...

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills. Soon...